Johnson & Johnson (JNJ) Buildings (2010 - 2021)
Johnson & Johnson (JNJ) posted Buildings of $12.5 billion for Q1 2021, up 5.26% sequentially from $11.9 billion in Q4 2019, and up 5.26% YoY from $11.9 billion in Q1 2020.
Johnson & Johnson (JNJ) Buildings (2010 - 2021) Analysis & Trends
Johnson & Johnson has reported Buildings for 10 years, with the latest figure at $12.5 billion in Q1 2021.
- Quarterly Buildings rose 5.26% year-over-year to $12.5 billion in Q1 2021, while the trailing twelve-month figure through Jan 2021 was $12.5 billion (up 5.26% YoY) and the FY2021 annual result came in at $12.5 billion, up 5.26% from the prior year.
- Buildings grew to $12.5 billion in Q1 2021 per JNJ's latest filing, from $11.9 billion in the prior quarter.
- Over five years, Buildings peaked at $12.5 billion in Q1 2021 and troughed at $10.1 billion in Q1 2017.
- A 4-year average of $11.4 billion and a median of $11.2 billion in 2017 frame the typical range for Buildings.
- The sharpest annual moves came in 2017 and 2018: Buildings gained 11.16% in 2017, then slipped 0.57% in 2018.
- Over 4 years, Buildings stood at $11.2 billion in 2017, then decreased by 0.57% to $11.2 billion in 2018, then increased by 6.27% to $11.9 billion in 2019, then increased by 5.26% to $12.5 billion in 2021.
- According to Business Quant data, Buildings over the past three periods registered $12.5 billion, $11.9 billion, and $11.2 billion for Q1 2021, Q4 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.97 Bn | 635.21 Bn | 17.26 Bn |
| 2 | AbbVie | 470.01 Bn | 463.44 Bn | 12.70 Bn |
| 3 | Merck | 380.54 Bn | 373.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.93 Bn | 295.24 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.10 Bn | 253.20 Bn | 12.86 Bn |
| 6 | Amgen | 237.12 Bn | 223.14 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.14 Bn | 179.96 Bn | 6.22 Bn |
| 8 | Pfizer | 161.51 Bn | 149.81 Bn | 10.94 Bn |
| 9 | Gsk | 105.87 Bn | 101.71 Bn | 8.24 Bn |
| 10 | Sanofi | 55.06 Bn | 47.68 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2021 | 12.50 Bn |
| Dec 29, 2019 | 11.88 Bn |
| Dec 30, 2018 | 11.18 Bn |
| Dec 31, 2017 | 11.24 Bn |
| Jan 1, 2017 | 10.11 Bn |
| Jan 3, 2016 | 9.83 Bn |
| Dec 28, 2014 | 10.05 Bn |
| Dec 29, 2013 | 10.42 Bn |
| Dec 30, 2012 | 10.05 Bn |
| Jan 1, 2012 | 9.39 Bn |
| Jan 2, 2011 | 9.08 Bn |
| Jan 3, 2010 | 8.86 Bn |